Suzanne Dvorak is leading Oceania Healthcare into what might be the most decisive moment in the New Zealand aged care operator's recent history — a time when record financial results are meeting genuine structural change. The company's FY26 results, announced this week, tell a story that stretches far beyond the headline numbers: 16% sales growth and $97.7 million in underlying EBITDA, though significant, are really just the beginning of what's happening inside this 51-facility network serving tens of thousands of New Zealanders in their later years.
The scale of Oceania Healthcare's business is staggering. Total assets now stand at $3.1 billion, and the company has settled 603 residential units across its retirement villages, representing a 16% increase on the previous year. What's more striking is the velocity of resales: 402 of those units were resales, generating $37 million in gains as New Zealanders continue to seek secure, integrated communities as they age. That same resale momentum, combined with new sales worth $375 million in gross value, suggests deep demand for Oceania's model of combining independent living with on-site aged care.
Behind these numbers lies a more fundamental shift. CEO Dvorak and Chair Liz Coutts have been reshaping the company's operational backbone — and the results are visible in the metrics that matter most. Care EBITDA per occupied bed jumped 40% to $27,000, a figure that reflects genuine improvements in how efficiently care is being delivered. More tellingly, underlying care profitability increased 43%, suggesting the company has cracked a problem that plagues many aged care operators worldwide: delivering better care without spiralling costs. That improvement has been fuelled by $13.2 million in operational efficiencies delivered this year, with another $7.2 million in annualised savings still to come.
The company's balance sheet transformation is equally important. Net debt fell by $121.4 million, a dramatic deleveraging that moves Oceania Healthcare from a highly leveraged position to something more sustainable. Gearing now sits at 30.1%, and total debt stands at $506.7 million. Much of that improvement came from an unexpected source: divesting seven sites for $51.1 million, proceeds that went directly to debt reduction rather than expansion — a disciplined choice in a sector hungry for growth.
If there's a challenge lurking in these otherwise buoyant results, it's the cash flow story. Free Cash Flow from Operations remains negative at $15.0 million outflow, though that's a substantial 64% improvement from the prior year. The company targets positive cash flow in FY27, which matters because the Board has decided against paying a dividend until that happens — a conservative but credible call. The Statutory Net Profit after Tax of just $0.1 million, down from $30.4 million the prior year, reflects the closure of the Wesley Institute of Nursing Education and lower property revaluations, not operational weakness.
What Oceania Healthcare has achieved is a pivot from expansion-at-all-costs toward sustainable, profitable growth. The company enters FY27, as Coutts noted, in "a materially stronger position," with management focused squarely on cash generation, disciplined capital allocation, and growth. For a nation watching its population age and wrestling with aged care capacity, that combination — better care, stronger finances, and disciplined growth — is exactly what the sector needs to see.